nach oben

Erschienen in:

15.09.2020 | Invited Papers

Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis

verfasst von: Ron Gilat, Eric D. Haunschild, Derrick M. Knapik, Aghogho Evuarherhe Jr, Kevin C. Parvaresh, Brian J. Cole

Erschienen in: International Orthopaedics | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Symptomatic knee osteoarthritis (OA) remains a substantial cause of pain and disability worldwide and effective management in young patients without indications for total knee arthroplasty remains challenging. Intra-articular injections represent a viable option in the non-operative treatment of knee OA. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two commonly utilized intra-articular treatment modalities that are of particular clinical interest in the current literature. The purpose of this manuscript is to provide a concise review of the current literature on the use of HA, PRP, and HA-PRP conjugates for the treatment of symptomatic knee OA.

Methods

A review of the literature utilizing PubMed, OVID/Medline, and Cochrane databases on basic science and clinical literature pertaining to preparation, composition, and outcomes of HA, PRP, and HA-PRP conjugates in patients with symptomatic knee OA.

Results

Both HA and PRP have been shown to be efficacious for the treatment of symptomatic knee OA, with HA injections providing limited short-term improvement, while PRP may provide greater therapeutic relief, particularly with the use of leukocyte-poor (LP-PRP) formulations. Despite limited data, the combination of different formulations of HA-PRP conjugates may provide a synergistic effect, resulting in a clinically significant improvement in both pain and function.

Conclusion

In patients with symptomatic knee OA, intra-articular HA and PRP provide short-term improvement in pain and function, while the efficacy of HA-PRP conjugates warrants further study.

Zhao J, Huang H, Liang G et al (2020) Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord 21:212–224. https://doi.org/10.1186/s12891-020-03262-wCrossRef

Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum 58:26–35. https://doi.org/10.1002/art.23176CrossRefPubMedPubMedCentral

Mather RC, Koenig L, Kocher MS et al (2013) Societal and economic impact of anterior cruciate ligament tears. J Bone Joint Surg (Am Vol) 95:1751–1759. https://doi.org/10.2106/jbjs.l.01705CrossRef

Chahla J, Mandelbaum BR (2018) Biological treatment for osteoarthritis of the knee: moving from bench to bedside—current practical concepts. Arthroscopy 34:1719–1729. https://doi.org/10.1016/j.arthro.2018.01.048CrossRefPubMed

Lane NE, Brandt K, Hawker G et al (2011) OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthr Cartil 19:478–482. https://doi.org/10.1016/j.joca.2010.09.013CrossRef

Brown GA (2013) AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 21:577–579. https://doi.org/10.5435/00124635-201309020-00009CrossRefPubMed

Carr AJ, Robertsson O, Graves S et al (2012) Knee replacement. Lancet (British edition) 379:1331–1340. https://doi.org/10.1016/S0140-6736(11)60752-6CrossRef

Waddell DD (2007) Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging 24:629–642. https://doi.org/10.2165/00002512-200724080-00002CrossRefPubMed

Yaftali NA, Weber K (2019) Corticosteroids and hyaluronic acid injections. Clin Sports Med 38:1–15. https://doi.org/10.1016/j.csm.2018.08.006CrossRefPubMed

10.

Miller LE, Fredericson M, Altman RD (2020) Hyaluronic acid injections or oral nonsteroidal anti-inflammatory drugs for knee osteoarthritis: systematic review and meta-analysis of randomized trials. Orthop J Sports Med 8:232596711989790. https://doi.org/10.1177/2325967119897909CrossRef

11.

Jüni P, Reichenbach S, Trelle S et al (2007) Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 56:3610–3619. https://doi.org/10.1002/art.23026CrossRefPubMed

12.

Dahl LB, Dahl IM, Engström-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817–822. https://doi.org/10.1136/ard.44.12.817CrossRefPubMedPubMedCentral

13.

Vincent P (2019) Intra-articular hyaluronic acid in the symptomatic treatment of knee osteoarthritis: a meta-analysis of single-injection products. Curr Ther Res 90:39–51. https://doi.org/10.1016/j.curtheres.2019.02.003CrossRefPubMedPubMedCentral

14.

Strand V, McIntyre LF, Beach WR et al (2015) Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials. J Pain Res 8:217–228. https://doi.org/10.2147/JPR.S83076CrossRefPubMedPubMedCentral

15.

Vilchez-Cavazos F, Millán-Alanís JM, Blázquez-Saldaña J et al (2019) Comparison of the clinical effectiveness of single versus multiple injections of platelet-rich plasma in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Orthop J Sports Med 7:2325967119887116. https://doi.org/10.1177/2325967119887116CrossRefPubMedPubMedCentral

16.

Fortier LA, Barker JU, Strauss EJ et al (2011) The role of growth factors in cartilage repair. Clin Orthop Relat Res 469:2706–2715. https://doi.org/10.1007/s11999-011-1857-3CrossRefPubMedPubMedCentral

17.

Patel S, Dhillon MS, Aggarwal S et al (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41:356–364. https://doi.org/10.1177/0363546512471299CrossRefPubMed

18.

Andia I, Maffulli N (2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 9:721–730. https://doi.org/10.1038/nrrheum.2013.141CrossRefPubMed

19.

Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 5:54–67. https://doi.org/10.1186/ar623CrossRefPubMedPubMedCentral

20.

Kon E, Filardo G, Drobnic M et al (2012) Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 20:436–449. https://doi.org/10.1007/s00167-011-1713-8CrossRefPubMed

21.

Delmage JM, Powars DR, Jaynes PK, Allerton SE (1986) The selective suppression of immunogenicity by hyaluronic acid. Ann Clin Lab Sci 16:303–310PubMed

22.

Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 32:10–37. https://doi.org/10.1053/sarh.2002.33720CrossRefPubMed

23.

Bannuru RR, Osani MC, Vaysbrot EE et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil 27:1578–1589. https://doi.org/10.1016/j.joca.2019.06.011CrossRef

24.

Altman RD, Bedi A, Karlsson J et al (2016) Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. Am J Sports Med 44:2158–2165. https://doi.org/10.1177/0363546515609599CrossRefPubMed

25.

Phillips M, Vannabouathong C, Devji T et al (2020) Differentiating factors of intra-articular injectables have a meaningful impact on knee osteoarthritis outcomes: a network meta-analysis. Knee Surg Sports Traumatol Arthrosc. https://doi.org/10.1007/s00167-019-05763-1

26.

Campbell KA, Erickson BJ, Saltzman BM et al (2015) Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analyses. Arthroscopy 31:2036–45.e14. https://doi.org/10.1016/j.arthro.2015.03.030CrossRefPubMed

27.

Rutjes AWS, Jüni P, da Costa BR et al (2012) Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med 157:180–191. https://doi.org/10.7326/0003-4819-157-3-201208070-00473CrossRefPubMed

28.

Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10:225–228. https://doi.org/10.1097/00008505-200110000-00002CrossRefPubMed

29.

Foster TE, Puskas BL, Mandelbaum BR et al (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37:2259–2272. https://doi.org/10.1177/0363546509349921CrossRefPubMed

30.

Beitzel K, Allen D, Apostolakos J et al (2015) US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. J Knee Surg 28:29–34. https://doi.org/10.1055/s-0034-1390030CrossRefPubMed

31.

Russell RP, Apostolakos J, Hirose T, et al (2013) Variability of platelet-rich plasma preparations. Sports Med Arthrosc Rev 21

32.

Mazzocca AD, McCarthy MBR, Chowaniec DM et al (2012) Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 94:308–316. https://doi.org/10.2106/JBJS.K.00430CrossRefPubMed

33.

Malanga G, Jayaram P (2017) Need for proper classification of PRP: letter to the editor. Am J Sports Med 45:NP23–NP24. https://doi.org/10.1177/0363546517693989CrossRefPubMed

34.

Mautner K, Malanga GA, Smith J et al (2015) A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R 7:S53–S59. https://doi.org/10.1016/j.pmrj.2015.02.005CrossRefPubMed

35.

DeLong JM, Russell RP, Mazzocca AD (2012) Platelet-rich plasma: the PAW classification system. Arthroscopy : the journal of arthroscopic & related surgery 28:998–1009. https://doi.org/10.1016/j.arthro.2012.04.148CrossRef

36.

Mishra A, Harmon K, Woodall J, Vieira A (2012) Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 13:1185–1195. https://doi.org/10.2174/138920112800624283CrossRefPubMed

37.

Magalon J, Chateau AL, Bertrand B et al (2016) DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med 2:e000060. https://doi.org/10.1136/bmjsem-2015-000060CrossRefPubMedPubMedCentral

38.

Chahla J, Cinque ME, Piuzzi NS et al (2017) A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 99:1769–1779. https://doi.org/10.2106/JBJS.16.01374CrossRefPubMed

39.

Yaşar Şirin D, Yılmaz İ, İsyar M et al (2017) Does leukocyte-poor or leukocyte-rich platelet-rich plasma applied with biopolymers have superiority to conventional platelet-rich plasma applications on chondrocyte proliferation? Jt Dis Relat Surg 28:142–151. https://doi.org/10.5606/ehc.2017.55186CrossRef

40.

Riboh JC, Saltzman BM, Yanke AB et al (2016) Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 44:792–800. https://doi.org/10.1177/0363546515580787CrossRefPubMed

41.

Miller LE, Parrish WR, Roides B, Bhattacharyya S (2016) Effect of leukocyte concentration on the efficacy of PRP in the treatment of knee OA: letter to the editor. Am J Sports Med 44:NP65–NP66. https://doi.org/10.1177/0363546516676458CrossRefPubMed

42.

Milants C, Bruyère O, Kaux J-F (2017) Responders to platelet-rich plasma in osteoarthritis: a technical analysis. Biomed Res Int 2017:7538604. https://doi.org/10.1155/2017/7538604CrossRefPubMedPubMedCentral

43.

Brandl A, Angele P, Roll C et al (2010) Influence of the growth factors PDGF-BB, TGF-β1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J Orthop Res 28:354–360. https://doi.org/10.1002/jor.21007CrossRefPubMed

44.

Durant TJS, Dwyer CR, McCarthy MBR et al (2016) Protective nature of platelet-rich plasma against chondrocyte death when combined with corticosteroids or local anesthetics. Am J Sports Med 45:218–225. https://doi.org/10.1177/0363546516664161CrossRefPubMed

45.

Sundman EA, Cole BJ, Karas V et al (2014) The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 42:35–41. https://doi.org/10.1177/0363546513507766CrossRefPubMed

46.

Lin K-Y, Yang C-C, Hsu C-J et al (2019) Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebo-controlled clinical trial. Arthroscopy 35:106–117. https://doi.org/10.1016/j.arthro.2018.06.035CrossRefPubMed

47.

Cole BJ, Karas V, Hussey K et al (2017) Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis. Am J Sports Med 45:339–346. https://doi.org/10.1177/0363546516665809CrossRefPubMed

48.

Kon E, Mandelbaum B, Buda R et al (2011) Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 27:1490–1501. https://doi.org/10.1016/j.arthro.2011.05.011CrossRefPubMed

49.

Tavassoli M, Janmohammadi N, Hosseini A et al (2019) Single- and double-dose of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: a randomized controlled trial. World J Orthod 10:310–326. https://doi.org/10.5312/wjo.v10.i9.310CrossRef

50.

Feller J (2016) Platelet-rich plasma injections were not better than hyaluronic acid injections for knee joint degeneration. J Bone Joint Surg Am 98:315. https://doi.org/10.2106/JBJS.15.01441CrossRefPubMed

51.

di Martino A, di Matteo B, Papio T et al (2019) Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial. Am J Sports Med 47:347–354. https://doi.org/10.1177/0363546518814532CrossRefPubMed

52.

XIX CONGRESSO NAZIONALE S.I.C.O.O.P. SOCIETA’ ITALIANA CHIRURGHI ORTOPEDICI DELL’OSPEDALITA’ PRIVATA ACCREDITATA, Papalia R, Zampogna B et al (2019) The combined use of platelet rich plasma and hyaluronic acid: prospective results for the treatment of knee osteoarthritis. J Biol Regul Homeost Agents 33:21–28

53.

Chen P, Huang L, Ma Y et al (2019) Intra-articular platelet-rich plasma injection for knee osteoarthritis: a summary of meta-analyses. J Orthop Surg Res 14:385. https://doi.org/10.1186/s13018-019-1363-yCrossRefPubMedPubMedCentral

54.

Joshi Jubert N, Rodríguez L, Reverté-Vinaixa MM, Navarro A (2017) Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop J Sports Med 5:2325967116689386. https://doi.org/10.1177/2325967116689386CrossRefPubMedPubMedCentral

55.

Forogh B, Mianehsaz E, Shoaee S et al (2016) Effect of single injection of platelet-rich plasma in comparison with corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial. J Sports Med Phys Fitness 56:901–908PubMed

56.

Paterson KL, Hunter DJ, Metcalf BR et al (2018) Efficacy of intra-articular injections of platelet-rich plasma as a symptom- and disease-modifying treatment for knee osteoarthritis - the RESTORE trial protocol. BMC Musculoskelet Disord 19:272. https://doi.org/10.1186/s12891-018-2205-5CrossRefPubMedPubMedCentral

57.

Chahla J, Cole BJ (2019) Editorial commentary: platelet-rich plasma for knee osteoarthritis: a “novel” and effective symptomatic approach. Arthroscopy : the journal of arthroscopic & related surgery 35:118–120CrossRef

58.

Cook CS, Smith PA (2018) Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Curr Rev Musculoskelet Med 11:583–592. https://doi.org/10.1007/s12178-018-9524-xCrossRefPubMedPubMedCentral

59.

Guillibert C, Charpin C, Raffray M et al (2019) Single injection of high volume of autologous pure PRP provides a significant improvement in knee osteoarthritis: a prospective routine care study. Int J Mol Sci 20:1327. https://doi.org/10.3390/ijms20061327CrossRefPubMedCentral

60.

Louis ML, Magalon J, Jouve E et al (2018) Growth factors levels determine efficacy of platelets rich plasma injection in knee osteoarthritis: a randomized double blind noninferiority trial compared with Viscosupplementation. Arthroscopy : the journal of arthroscopic & related surgery 34:1530–1540.e2. https://doi.org/10.1016/j.arthro.2017.11.035CrossRef

61.

Görmeli G, Görmeli CA, Ataoglu B et al (2017) Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial. Knee Surg Sports Traumatol Arthrosc 25:958–965. https://doi.org/10.1007/s00167-015-3705-6CrossRefPubMed

62.

Hohmann E, Tetsworth K, Glatt V (2020) Is platelet-rich plasma effective for the treatment of knee osteoarthritis? A systematic review and meta-analysis of level 1 and 2 randomized controlled trials. Eur J Orthop Surg Traumatol 30:955–967. https://doi.org/10.1007/s00590-020-02623-4CrossRefPubMed

63.

Xing D, Wang B, Zhang W et al (2017) Intra-articular platelet-rich plasma injections for knee osteoarthritis: an overview of systematic reviews and risk of bias considerations. Int J Rheum Dis 20:1612–1630CrossRefPubMed

64.

Lee M-I, Kim J-H, Kwak H-H et al (2019) A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis. J Orthop Surg Res 14:314. https://doi.org/10.1186/s13018-019-1352-1CrossRefPubMedPubMedCentral

65.

Russo F, D’Este M, Vadalà G et al (2016) Platelet rich plasma and hyaluronic acid blend for the treatment of osteoarthritis: rheological and biological evaluation. PLoS One 11:e0157048. https://doi.org/10.1371/journal.pone.0157048CrossRefPubMedPubMedCentral

66.

Chen W-H, Lo W-C, Hsu W-C et al (2014) Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials 35:9599–9607. https://doi.org/10.1016/j.biomaterials.2014.07.058CrossRefPubMed

67.

Chiou C-S, Wu C-M, Dubey NK et al (2018) Mechanistic insight into hyaluronic acid and platelet-rich plasma-mediated anti-inflammatory and anti-apoptotic activities in osteoarthritic mice. Aging 10:4152–4165. https://doi.org/10.18632/aging.101713CrossRefPubMedPubMedCentral

68.

Saturveithan C, Premganesh G, Fakhrizzaki S et al (2016) Intra-articular hyaluronic acid (HA) and platelet rich plasma (PRP) injection versus hyaluronic acid (HA) injection alone in patients with grade III and IV knee osteoarthritis (OA): a retrospective study on functional outcome. Malays Orthop J 10:35–40. https://doi.org/10.5704/MOJ.1607.007CrossRefPubMedPubMedCentral

69.

Lana JFSD, Weglein A, Sampson SE et al (2016) Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. J Stem Cells Regen Med 12:69–78. https://doi.org/10.46582/jsrm.1202011CrossRefPubMedPubMedCentral

70.

Yu W, Xu P, Huang G, Liu L (2018) Clinical therapy of hyaluronic acid combined with platelet-rich plasma for the treatment of knee osteoarthritis. Exp Ther Med 16:2119–2125. https://doi.org/10.3892/etm.2018.6412CrossRefPubMedPubMedCentral

Titel: Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis
verfasst von: Ron Gilat
Eric D. Haunschild
Derrick M. Knapik
Aghogho Evuarherhe Jr
Kevin C. Parvaresh
Brian J. Cole
Publikationsdatum: 15.09.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: International Orthopaedics / Ausgabe 2/2021
Print ISSN: 0341-2695
Elektronische ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-020-04801-9

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis

Abstract

Purpose

Methods

Results

Conclusion

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Zwei neue Alternativen zu TNF-Inhibitoren bei axSpA

Update Orthopädie und Unfallchirurgie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Human bone marrow mesenchymal stem cell injection in subchondral lesions of knee osteoarthritis: a prospective randomized study versus contralateral arthroplasty at a mean fifteen year follow-up

Clinical-radiological outcomes and complications after total ankle replacement through a lateral transfibular approach: a retrospective evaluation at a mid-term follow-up

The effects of systemic ozone application and hyperbaric oxygen therapy on knee osteoarthritis: an experimental study in rats

Current hip cartilage regeneration/repair modalities: a scoping review of biologics and surgery

Effects of umbilical cord mesenchymal stem cells loaded with graphene oxide granular lubrication on cytokine levels in animal models of knee osteoarthritis

Osteoarthritis: an ancient disease, an unsolved conundrum

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Zwei neue Alternativen zu TNF-Inhibitoren bei axSpA

Update Orthopädie und Unfallchirurgie